Macrodomains: Structure, Function, Evolution, and Catalytic Activities

Annual Review of Biochemistry

Volumn 85, Issue , 2016, Pages 431-454

  Rack, Johannes Gregor Matthias ^a   Perina, Dragutin ^b   Ahel, Ivan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

ADP ribose; NAD; PARG; PARP family; Posttranslational modifications

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; ALC1 PROTEIN; BACTERIAL PROTEIN; GDAP2 PROTEIN; GLYCOSIDASE; HYDROLASE; MACRODOMAIN 1; MACRODOMAIN 2; MACRODOMAIN PROTEIN; MACRODOMAIN PROTEIN INHIBITOR; MONO(ADP RIBOSYL)HYDROLASE; PARG PROTEIN; POLY(ADP RIBOSYL)GLYCOHYDROLASE; PROTEIN; PROTEIN INHIBITOR; RNA BINDING PROTEIN; TERMINAL ADPR PROTEIN GLYCOHYDROLASE 1; UNCLASSIFIED DRUG; VIRUS PROTEIN; ESCHERICHIA COLI PROTEIN; ISOENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARG PROTEIN, E COLI; REPRESSOR PROTEIN;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; CALCIUM SIGNALING; CATALYSIS; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MICROORGANISM; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; RNA BINDING; SECOND MESSENGER; VIRUS INFECTION; ANIMAL; CHEMISTRY; DNA DAMAGE; DNA REPAIR; ENZYMOLOGY; GENETICS; METABOLISM; MULTIGENE FAMILY; NEOPLASM; PATHOLOGY; PHYLOGENY; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY; VIROLOGY;

ADENOSINE DIPHOSPHATE RIBOSE; ANIMALS; DNA DAMAGE; DNA REPAIR; ESCHERICHIA COLI PROTEINS; EVOLUTION, MOLECULAR; HUMANS; ISOENZYMES; MULTIGENE FAMILY; NEOPLASMS; PHYLOGENY; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN DOMAINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY, PROTEIN; VIRUS DISEASES;

EID: 84974663169     PISSN: 00664154     EISSN: 15454509     Source Type: Book Series    
DOI: 10.1146/annurev-biochem-060815-014935     Document Type: Article

References (150)

1. Till S, Ladurner AG. 2009. SensingNAD metabolites throughmacro domains. Front. Biosci. 14:3246-58
2. Lee HJ, Shieh CK, Gorbalenya AE, Koonin EV, La Monica N, et al. 1991. The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology 180:567-82
3. Pehrson JR, Fried VA. 1992. MacroH2A, a core histone containing a large nonhistone region. Science 257:1398-400
4. Taverna SD, LiH, Ruthenburg AJ, Allis CD, Patel DJ. 2007. How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat. Struct. Mol. Biol. 14:1025-40
5. Ahel D, Horejsi Z, Wiechens N, Polo SE, Garcia-Wilson E, et al. 2009. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science 325:1240-43
6. Karras GI, Kustatscher G, Buhecha HR, Allen MD, Pugieux C, et al. 2005. The macro domain is an ADP-ribose binding module. EMBO J. 24:1911-20
7. KrausWL. 2009. New functions for an ancient domain. Nat. Struct. Mol. Biol. 16:904-7
8. Chen D, Vollmar M, Rossi MN, Phillips C, Kraehenbuehl R, et al. 2011. Identification of macrodomain proteins as novel O-acetyl-ADP-ribose deacetylases. J. Biol. Chem. 286:13261-71
9. Johnson MA, Chatterjee A, Neuman BW, Wuthrich K. 2010. SARS coronavirus unique domain: Threedomain molecular architecture in solution and RNA binding. J. Mol. Biol. 400:724-42
10. Tan J, Vonrhein C, Smart OS, Bricogne G, Bollati M, et al. 2009. The SARS-unique domain (SUD) of SARS coronavirus contains two macrodomains that bind G-quadruplexes. PLOS Pathog. 5:e1000428
11. Feijs KL, Forst AH, Verheugd P, Luscher B. 2013. Macrodomain-containing proteins: regulating new intracellular functions of mono(ADP-ribosyl)ation. Nat. Rev. Mol. Cell. Biol. 14:443-51
12. Han W, Li X, Fu X. 2011. The macro domain protein family: structure, functions, and their potential therapeutic implications. Mutat. Res. 727:86-103
13. Maas NM, Van de Putte T, Melotte C, Francis A, Schrander-Stumpel CT, et al. 2007. The C20orf133 gene is disrupted in a patient with Kabuki syndrome. J. Med. Genet. 44:562-69
14. Buschbeck M, Uribesalgo I, Wibowo I, Rue P, Martin D, et al. 2009. The histone variant macroH2A is an epigenetic regulator of key developmental genes. Nat. Struct. Mol. Biol. 16:1074-79
15. Timinszky G, Till S, Hassa PO, Hothorn M, Kustatscher G, et al. 2009. A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation. Nat. Struct. Mol. Biol. 16:923-29
16. Kim W, Chakraborty G, Kim S, Shin J, Park CH, et al. 2012. Macro histone H2A1. 2 (macroH2A1) protein suppresses mitotic kinase VRK1 during interphase. J. Biol. Chem. 287:5278-89
17. Chen L, HuL, ChanTH, TsaoGS, XieD, et al. 2009. Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l ) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival. Hepatology 50:122-29
18. Eriksson KK, Cervantes-Barragan L, Ludewig B, Thiel V. 2008. Mouse hepatitis virus liver pathology is dependent on ADP-ribose-1-phosphatase, a viral function conserved in the alpha-like supergroup. J. Virol. 82:12325-34
19. Barkauskaite E, Jankevicius G, Ladurner AG, Ahel I, Timinszky G. 2013. The recognition and removal of cellular poly(ADP-ribose) signals. FEBS J. 280:3491-507
20. Perina D, Mikoc? A, Ahel J, Cetkovic H, Z? aja R, Ahel I. 2014. Distribution of protein poly(ADPribosyl) ation systems across all domains of life. DNA Repair 23:4-16
21. Feijs KL, Verheugd P, Luscher B. 2013. Expanding functions of intracellular resident mono-ADPribosylation in cell physiology. FEBS J. 280:3519-29
22. Gibson BA, KrausWL. 2012. Newinsights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat. Rev. Mol. Cell. Biol. 13:411-24
23. Denu JM. 2005. The Sir 2 family of protein deacetylases. Curr. Opin. Chem. Biol. 9:431-40
24. Sauve AA, Youn DY. 2012. Sirtuins: NAD+-dependent deacetylase mechanism and regulation. Curr. Opin. Chem. Biol. 16:535-43
25. Rack JG, Morra R, Barkauskaite E, Kraehenbuehl R, Ariza A, et al. 2015. Identification of a class of protein ADP-ribosylating sirtuins in microbial pathogens. Mol. Cell 59:309-20
26. Kowieski TM, Lee S, Denu JM. 2008. Acetylation-dependent ADP-ribosylation by Trypanosoma brucei Sir2. J. Biol. Chem. 283:5317-26
27. Barkauskaite E, Jankevicius G, Ahel I. 2015. Structures and mechanisms of enzymes employed in the synthesis and degradation of PARP-dependent protein ADP-ribosylation. Mol. Cell 58:935-46
28. Vyas S, Matic I, Uchima L, Rood J, Zaja R, et al. 2014. Family-wide analysis of poly(ADP-ribose) polymerase activity. Nat. Commun. 5:4426
29. Kleine H, Poreba E, Lesniewicz K, Hassa PO, Hottiger MO, et al. 2008. Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation. Mol. Cell 32:57-69
30. LangelierMF, Pascal JM. 2013. PARP-1 mechanism for couplingDNA damage detection to poly(ADPribose) synthesis. Curr. Opin. Struct. Biol. 23:134-43
31. Miwa M, Ishihara M, Takishima S, Takasuka N, Maeda M, et al. 1981. The branching and linear portions of poly(adenosine diphosphate ribose) have the same ?(1?2) ribose-ribose linkage. J. Biol. Chem. 256:2916-21
32. Martzen MR, McCraith SM, Spinelli SL, Torres FM, Fields S, et al. 1999. A biochemical genomics approach for identifying genes by the activity of their products. Science 286:1153-55
33. Shull NP, Spinelli SL, Phizicky EM. 2005. A highly specific phosphatase that acts on ADP-ribose 1-phosphate, a metabolite of tRNA splicing in Saccharomyces cerevisiae. Nucleic Acids Res. 33:650-60
34. Jankevicius G, Hassler M, Golia B, Rybin V, Zacharias M, et al. 2013. A family of macrodomain proteins reverses cellular mono-ADP-ribosylation. Nat. Struct. Mol. Biol. 20:508-14
35. Barkauskaite E, Brassington A, Tan ES, Warwicker J, Dunstan MS, et al. 2013. Visualization of poly(ADP-ribose) bound to PARG reveals inherent balance between exo-and endo-glycohydrolase activities. Nat. Commun. 4:2164
36. Miwa M, Sugimura T. 1971. Splitting of the ribose-ribose linkage of poly(adenosine diphosphate-ribose) by a calf thymus extract. J. Biol. Chem. 246:6362-64
37. Peterson FC, Chen D, Lytle BL, Rossi MN, Ahel I, et al. 2011. Orphan macrodomain protein (human C6orf130) is an O-acyl-ADP-ribose deacylase: solution structure and catalytic properties. J. Biol. Chem. 286:35955-65
38. Rosenthal F, Feijs KL, Frugier E, Bonalli M, Forst AH, et al. 2013. Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases. Nat. Struct. Mol. Biol. 20:502-7
39. Sharifi R, Morra R, Appel CD, Tallis M, Chioza B, et al. 2013. Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease. EMBO J. 32:1225-37
40. Slade D, Dunstan MS, Barkauskaite E, Weston R, Lafite P, et al. 2011. The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase. Nature 477:616-20
41. Fliegert R, Gasser A, Guse AH. 2007. Regulation of calcium signalling by adenine-based second messengers. Biochem. Soc. Trans. 35:109-14
42. Neuvonen M, AholaT. 2009. Differential activities of cellular and viral macro domain proteins in binding of ADP-ribose metabolites. J. Mol. Biol. 385:212-25
43. Chatterjee A, Johnson MA, Serrano P, Pedrini B, Joseph JS, et al. 2009. Nuclear magnetic resonance structure shows that the severe acute respiratory syndrome coronavirus-unique domain contains a macrodomain fold. J. Virol. 83:1823-36
44. Allen MD, Buckle AM, Cordell SC, Lowe J, Bycroft M. 2003. The crystal structure of AF1521 a protein from Archaeoglobus fulgidus with homology to the non-histone domain of macroH2A. J. Mol. Biol. 330:503-11
45. EgloffMP, Malet H, Putics A, Heinonen M, Dutartre H, et al. 2006. Structural and functional basis for ADP-ribose and poly(ADP-ribose) binding by viral macro domains. J. Virol. 80:8493-502
46. Kustatscher G, Hothorn M, Pugieux C, Scheffzek K, Ladurner AG. 2005. Splicing regulates NAD metabolite binding to histone macroH2A. Nat. Struct. Mol. Biol. 12:624-25
47. Gottschalk AJ, Timinszky G, Kong SE, Jin J, Cai Y, et al. 2009. Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler. PNAS 106:13770-74
48. Forst AH, Karlberg T, Herzog N, Thorsell AG, Gross A, et al. 2013. Recognition of mono-ADPribosylated ARTD10 substrates by ARTD8 macrodomains. Structure 21:462-75
49. Zaja R, Mikoc A, Barkauskaite E, Ahel I. 2012. Molecular insights into poly(ADP-ribose) recognition and processing. Biomolecules 3:1-17
50. Tallis M, Morra R, Barkauskaite E, Ahel I. 2014. Poly(ADP-ribosyl)ation in regulation of chromatin structure and the DNA damage responsE. Chromosoma 123:79-90
51. Hirsch BM, Burgos ES, Schramm VL. 2014. Transition-state analysis of 2-O-acetyl-ADP-ribose hydrolysis by human macrodomain 1. ACS Chem. Biol. 9:2255-62
52. DunstanMS, BarkauskaiteE, Lafite P, KnezevicCE, BrassingtonA, et al. 2012. Structure and mechanism of a canonical poly(ADP-ribose) glycohydrolase. Nat. Commun. 3:878
53. Patel CN, Koh DW, Jacobson MK, Oliveira MA. 2005. Identification of three critical acidic residues of poly(ADP-ribose) glycohydrolase involved in catalysis: determining thePARGcatalytic domain. Biochem. J. 388:493-500
54. Tucker JA, Bennett N, Brassington C, Durant ST, Hassall G, et al. 2012. Structures of the human poly (ADP-ribose) glycohydrolase catalytic domain confirm catalytic mechanism and explain inhibition by ADP-HPD derivatives. PLOS ONE 7:e50889
55. Kim IK, Kiefer JR, Ho CM, Stegeman RA, Classen S, et al. 2012. Structure of mammalian poly(ADPribose) glycohydrolase reveals a flexible tyrosine clasp as a substrate-binding element. Nat. Struct. Mol. Biol. 19:653-56
56. Lambrecht MJ, Brichacek M, Barkauskaite E, Ariza A, Ahel I, Hergenrother PJ. 2015. Synthesis of dimeric ADP-ribose and its structure with human poly(ADP-ribose) glycohydrolase. J. Am. Chem. Soc. 137:3558-64
57. Andrabi SA, Kim NS, Yu SW, Wang H, Koh DW, et al. 2006. Poly(ADP-ribose) (PAR) polymer is a death signal. PNAS 103:18308-13
58. DaughertyMD, Young JM, Kerns JA, Malik HS. 2014. Rapid evolution of PARP genes suggests a broad role for ADP-ribosylation in host-virus conflicts. PLOS Genet. 10:e1004403
59. de Souza RF, Aravind L. 2012. Identification of novel components of NAD-utilizingmetabolic pathways and prediction of their biochemical functions. Mol. BioSyst. 8:1661-77
60. Citarelli M, Teotia S, Lamb RS. 2010. Evolutionary history of the poly(ADP-ribose) polymerase gene family in eukaryotes. BMC Evol. Biol. 10:308
61. Gossmann TI, Ziegler M. 2014. Sequence divergence and diversity suggests ongoing functional diversification of vertebrate NAD metabolism. DNA Repair 23:39-48
62. Rass U, Ahel I, West SC. 2008. Molecular mechanism ofDNA deadenylation by the neurological disease protein Aprataxin. J. Biol. Chem. 283:33994-4001
63. McLennan AG. 2006. The Nudix hydrolase superfamily. Cell. Mol. Life Sci. 63:123-43
64. Tong L, Lee S, Denu JM. 2009. Hydrolase regulates NAD+ metabolites and modulates cellular redox. J. Biol. Chem. 284:11256-66
65. Palazzo L, Thomas B, Jemth AS, Colby T, Leidecker O, et al. 2015. Processing of protein ADPribosylation by Nudix hydrolases. Biochem. J. 468:293-301
66. Buschbeck M, Di Croce L. 2010. Approaching the molecular and physiological function of macroH2A variants. Epigenetics 5:118-23
67. Rasmussen TP, Huang T, Mastrangelo MA, Loring J, Panning B, Jaenisch R. 1999. Messenger RNAs encoding mouse histone macroH2A1 isoforms are expressed at similar levels in male and female cells and result from alternative splicing. Nucleic Acids Res. 27:3685-89
68. Posavec M, Timinszky G, Buschbeck M. 2013. Macro domains as metabolite sensors on chromatin. Cell. Mol. Life Sci. 70:1509-24
69. Turinetto V, Giachino C. 2015. Histone variants as emerging regulators of embryonic stem cell identity. Epigenetics 10:563-73
70. Creppe C, Janich P, Cantarino N, NogueraM, Valero V, et al. 2012. MacroH2A1 regulates the balance between self-renewal and differentiation commitment in embryonic and adult stem cells. Mol. Cell. Biol. 32:1442-52
71. Yildirim O, Hung JH, Cedeno RJ, Weng Z, Lengner CJ, Rando OJ. 2014. A system for genome-wide histone variant dynamics in ES cells reveals dynamic MacroH2A2 replacement at promoters. PLOS Genet. 10:e1004515
72. Doyen CM, An W, Angelov D, Bondarenko V, Mietton F, et al. 2006. Mechanism of polymerase II transcription repression by the histone variant macroH2A. Mol. Cell. Biol. 26:1156-64
73. Cantarino N, Douet J, Buschbeck M. 2013. MacroH2A-an epigenetic regulator of cancer. Cancer Lett. 336:247-52
74. Ryan DP, Owen-Hughes T. 2011. Snf2-family proteins: chromatin remodellers for any occasion. Curr. Opin. Chem. Biol. 15:649-56
75. Chen L, Chan TH, Yuan YF, Hu L, Huang J, et al. 2010. CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients. J. Clin. Investig. 120:1178-91
76. Ji X, Li J, Zhu L, Cai J, Zhang J, et al. 2013. CHD1L promotes tumor progression and predicts survival in colorectal carcinoma. J. Surg. Res. 185:84-91
77. Snider AC, Leong D, Wang QT, Wysocka J, Yao MW, Scott MP. 2013. The chromatin remodeling factor Chd1l is required in the preimplantation embryo. Biol. Open 2:121-31
78. Gottschalk AJ, Trivedi RD, Conaway JW, Conaway RC. 2012. Activation of the SNF2 family ATPase ALC1 by poly(ADP-ribose) in a stable ALC1PARP1nucleosome intermediate. J. Biol. Chem. 287:43527-32
79. ChengW, Su Y, Xu F. 2013. CHD1L: A novel oncogene. Mol. Cancer 12:170
80. Chen M, Huang JD, Hu L, Zheng BJ, Chen L, et al. 2009. Transgenic CHD1L expression in mouse induces spontaneous tumors. PLOS ONE 4:e6727
81. Brockschmidt A, Chung B, Weber S, Fischer DC, Kolatsi-Joannou M, et al. 2012. CHD1L: A new candidate gene for congenital anomalies of the kidneys and urinary tract (CAKUT). Nephrol. Dial. Transplant. 27:2355-64
82. Aguiar RC, Takeyama K, He C, Kreinbrink K, Shipp MA. 2005. B-aggressive lymphoma family proteins have unique domains that modulate transcription and exhibit poly(ADP-ribose) polymerase activity. J. Biol. Chem. 280:33756-65
83. Aguiar RC, Yakushijin Y, Kharbanda S, Salgia R, Fletcher JA, Shipp MA. 2000. BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration. Blood 96:4328-34
84. Juszczynski P, Kutok JL, Li C, Mitra J, Aguiar RC, Shipp MA. 2006. BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate. Mol. Cell. Biol. 26:5348-59
85. Hakmé A, Huber A, Dollé P, Schreiber V. 2008. The macroPARP genes parp-9 and parp-14 are developmentally and differentially regulated in mouse tissues. Dev. Dyn. 237:209-15
86. Yan Q, Xu R, Zhu L, Cheng X, Wang Z, et al. 2013. BAL1 and its partner E3 ligase, BBAP, link Poly(ADP-ribose) activation, ubiquitylation, and double-strand DNA repair independent of ATM, MDC1, and RNF8. Mol. Cell. Biol. 33:845-57
87. Camicia R, Bachmann SB, Winkler HC, Beer M, Tinguely M, et al. 2013. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFN STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma. J. Cell Sci. 126:1969-80
88. Guerrero-Preston R, Michailidi C, Marchionni L, Pickering CR, Frederick MJ, et al. 2014. Key tumor suppressor genes inactivated by "greater promoter"methylation and somaticmutations in head and neck cancer. Epigenetics 9:1031-46
89. Saito K, Tautz L, Mustelin T. 2007. The lipid-binding SEC14 domain. Biochim. Biophys. Acta 1771:719-26
90. Tong L, Denu JM. 2010. Function and metabolism of sirtuin metabolite O-acetyl-ADP-ribose. Biochim. Biophys. Acta 1804:1617-25
91. Han WD, Zhao YL, Meng YG, Zang L, Wu ZQ, et al. 2007. Estrogenically regulated LRP16 interacts with estrogen receptor ?and enhances the receptor's transcriptional activity. Endocr. Relat. Cancer 14:741-53
92. Yang J, Zhao YL, Wu ZQ, Si YL, Meng YG, et al. 2009. The single-macro domain protein LRP16 is an essential cofactor of androgen receptor. Endocr. Relat. Cancer 16:139-53
93. Mohseni M, Cidado J, Croessmann S, Cravero K, Cimino-Mathews A, et al. 2014. MACROD2 overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers. PNAS 111:17606-11
94. Rajaram M, Zhang J, Wang T, Li J, Kuscu C, et al. 2013. Two distinct categories of focal deletions in cancer genomes. PLOS ONE 8:e66264
95. Yao F, Kausalya JP, Sia YY, Teo AS, Lee WH, et al. 2015. Recurrent fusion genes in gastric cancer: CLDN18-ARHGAP26 induces loss of epithelial integrity. Cell Rep. 12:272-85
96. Meyer-Ficca ML, Meyer RG, Coyle DL, Jacobson EL, Jacobson MK. 2004. Human poly(ADP-ribose) glycohydrolase is expressed in alternative splice variants yielding isoforms that localize to different cell compartments. Exp. Cell Res. 297:521-32
97. Niere M, Mashimo M, Agledal L, Dölle C, Kasamatsu A, et al. 2012. ADP-ribosylhydrolase 3 (ARH3), not poly(ADP-ribose) glycohydrolase (PARG) isoforms, is responsible for degradation of mitochondrial matrix-associated poly(ADP-ribose). J. Biol. Chem. 287:16088-102
98. Feng X, Koh DW. 2013. Roles of poly(ADP-ribose) glycohydrolase in DNA damage and apoptosis. Int. Rev. Cell Mol. Biol. 304:227-81
99. Nikiforov A, Kulikova V, Ziegler M. 2015. The human NAD metabolome: functions, metabolism and compartmentalization. Crit. Rev. Biochem. Mol. Biol. 50:284-97
100. Hanai S, Kanai M, Ohashi S, Okamoto K, Yamada M, et al. 2004. Loss of poly(ADP-ribose) glycohydrolase causes progressive neurodegeneration in Drosophila melanogaster. PNAS 101:82-86
101. KohDW, Lawler AM, Poitras MF, SasakiM, Wattler S, et al. 2004. Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality. PNAS 101:17699-704
102. Haince JF, OuelletME, McDonald D, HendzelMJ, Poirier GG. 2006. Dynamic relocation of poly(ADPribose) glycohydrolase isoforms during radiation-inducedDNAdamage. Biochim. Biophys. Acta 1763:226-37
103. Mortusewicz O, Fouquerel E, Ame JC, Leonhardt H, Schreiber V. 2011. PARG is recruited to DNA damage sites through poly(ADP-ribose)-and PCNA-dependent mechanisms. Nucleic Acids Res. 39:5045-56
104. Cortes U, Tong WM, Coyle DL, Meyer-Ficca ML, Meyer RG, et al. 2004. Depletion of the 110-kilodalton isoform of poly(ADP-ribose) glycohydrolase increases sensitivity to genotoxic and endotoxic stress in mice. Mol. Cell. Biol. 24:7163-78
105. Burkle A, Virag L. 2013. Poly(ADP-ribose): PARadigms and PARadoxes. Mol. Aspects Med. 34:1046-65
106. Cuzzocrea S, Di PaolaR, MazzonE, CortesU, GenoveseT, et al. 2005. PARGactivitymediates intestinal injury induced by splanchnic artery occlusion and reperfusion. FASEB J. 19:558-66
107. Cuzzocrea S, Wang ZQ. 2005. Role of poly(ADP-ribose) glycohydrolase (PARG) in shock, ischemia and reperfusion. Pharmacol. Res. 52:100-8
108. Genovese T, Di Paola R, Catalano P, Li JH, Xu W, et al. 2004. Treatment with a novel poly(ADPribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in micE. Crit. Care Med. 32:1365-74
109. PatelNS, Cortes U, Di Poala R, Mazzon E, Mota-FilipeH, et al. 2005. Mice lacking the 110-kD isoform of poly(ADP-ribose) glycohydrolase are protected against renal ischemia/reperfusion injury. J. Am. Soc. Nephrol. 16:712-19
110. Burkle A. 2001. Physiology and pathophysiology of poly(ADP-ribosyl)ation. BioEssays 23:795-806
111. Chiarugi A. 2002. Poly(ADP-ribose) polymerase: Killer or conspirator? The 'suicide hypothesis' revisited. Trends Pharmacol. Sci. 23:122-29
112. Ha HC, Snyder SH. 1999. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. PNAS 96:13978-82
113. Fonfria E, Marshall IC, Benham CD, Boyfield I, Brown JD, et al. 2004. TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP-ribose) polymerase. Br. J. Pharmacol. 143:186-92
114. Dolle C, Niere M, Lohndal E, Ziegler M. 2010. Visualization of subcellular NAD pools and intraorganellar protein localization by poly-ADP-ribose formation. Cell. Mol. Life Sci. 67:433-43
115. Perraud AL, Fleig A, Dunn CA, Bagley LA, Launay P, et al. 2001. ADP-ribose gating of the calciumpermeable LTRPC2 channel revealed by Nudix motif homology. Nature 411:595-99
116. Tóth B, Iordanov I, Csanády L. 2015. Ruling out pyridine dinucleotides as true TRPM2 channel activators reveals novel direct agonist ADP-ribose-2-phosphate. J. Gen. Physiol. 145:419-30
117. Formentini L, Macchiarulo A, Cipriani G, Camaioni E, Rapizzi E, et al. 2009. Poly(ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure. J. Biol. Chem. 284:17668-76
118. Lin S, Gasmi L, Xie Y, Ying K, Gu S, et al. 2002. Cloning, expression and characterisation of a human Nudix hydrolase specific for adenosine 5-diphosphoribose (ADP-ribose). Biochim. Biophys. Acta 1594:127-35
119. Nordlund S, Hogbom M. 2013. ADP-ribosylation, a mechanism regulating nitrogenase activity. FEBS J. 280:3484-90
120. Eastman D, Dworkin M. 1994. Endogenous ADP-ribosylation during development of the prokaryote Myxococcus xanthus. Microbiology 140(Pt 11):3167-76
121. Penyige A, Keseru J, Fazakas F, Schmelczer I, Szirak K, et al. 2009. Analysis and identification of ADPribosylated proteins of Streptomyces coelicolor M145. J. Microbiol. 47:549-56
122. SpaldingMD, Prigge ST. 2010. Lipoic acid metabolism inmicrobial pathogens. Microbiol. Mol. Biol. Rev. 74:200-28
123. Enjalbert B, Rachini A, VediyappanG, Pietrella D, SpaccapeloR, et al. 2009. Amultifunctional, synthetic Gaussia princeps luciferase reporter for live imaging of Candida albicans infections. Infect. Immun. 77:4847-58
124. Surmann K, Michalik S, Hildebrandt P, Gierok P, Depke M, et al. 2014. Comparative proteome analysis reveals conserved and specific adaptation patterns of Staphylococcus aureus after internalization by different types of human non-professional phagocytic host cells. Front. Microbiol. 5:392
125. Sberro H, Leavitt A, Kiro R, Koh E, Peleg Y, et al. 2013. Discovery of functional toxin/antitoxin systems in bacteria by shotgun cloning. Mol. Cell 50:136-48
126. Fehr AR, Athmer J, Channappanavar R, Phillips JM, Meyerholz DK, Perlman S. 2015. The nsp3 macrodomain promotes virulence in mice with coronavirus-induced encephalitis. J. Virol. 89:1523-36
127. Kuri T, Eriksson KK, Putics A, Zust R, Snijder EJ, et al. 2011. The ADP-ribose-1-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses. J. Gen. Virol. 92:1899-905
128. Basta HA, Cleveland SB, Clinton RA, Dimitrov AG, McClure MA. 2009. Evolution of teleost fish retroviruses: characterization of new retroviruses with cellular genes. J. Virol. 83:10152-62
129. Malet H, Coutard B, Jamal S, Dutartre H, Papageorgiou N, et al. 2009. The crystal structures of Chikungunya and Venezuelan equine encephalitis virus nsP3 macro domains define a conserved adenosine binding pocket. J. Virol. 83:6534-45
130. Malet H, Dalle K, Bremond N, Tocque F, Blangy S, et al. 2006. Expression, purification and crystallization of the SARS-CoV macro domain. Acta Crystallogr. Sect. F 62:405-8
131. Putics A, Slaby J, Filipowicz W, Gorbalenya AE, Ziebuhr J. 2006. ADP-ribose-1- phosphatase activities of the human coronavirus 229E and SARS coronavirus X domains. Adv. Exp. Med. Biol. 581:93-96
132. Gorbalenya AE, Enjuanes L, Ziebuhr J, Snijder EJ. 2006. Nidovirales: evolving the largest RNA virus genome. Virus Res. 117:17-37
133. LaStarza MW, Lemm JA, Rice CM. 1994. Genetic analysis of the nsP3 region of Sindbis virus: evidence for roles in minus-strand and subgenomic RNA synthesis. J. Virol. 68:5781-91
134. Neuman BW, Joseph JS, Saikatendu KS, Serrano P, Chatterjee A, et al. 2008. Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3. J. Virol. 82:5279-94
135. Neuvonen M, Kazlauskas A, Martikainen M, Hinkkanen A, Ahola T, Saksela K. 2011. SH3 domain-mediated recruitment of host cell amphiphysins by alphavirus nsP3 promotes viral RNA replication. PLOS Pathog. 7:e1002383
136. Park E, Griffin DE. 2009. The nsP3 macro domain is important for Sindbis virus replication in neurons and neurovirulence in mice. Virology 388:305-14
137. Putics A, Filipowicz W, Hall J, Gorbalenya AE, Ziebuhr J. 2005. ADP-ribose-1-monophosphatase: A conserved coronavirus enzyme that is dispensable for viral replication in tissue culture. J. Virol. 79:12721-31
138. Atasheva S, Akhrymuk M, Frolova EI, Frolov I. 2012. New PARP gene with an anti-alphavirus function. J. Virol. 86:8147-60
139. Atasheva S, Frolova EI, Frolov I. 2014. Interferon-stimulated poly(ADP-Ribose) polymerases are potent inhibitors of cellular translation and virus replication. J. Virol. 88:2116-30
140. Bertoletti A, Maini MK. 2000. Protection or damage: A dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr. Opin. Microbiol. 3:387-92
141. Gu J, Korteweg C. 2007. Pathology and pathogenesis of severe acute respiratory syndrome. Am. J. Pathol. 170:1136-47
142. Kusov Y, Tan J, Alvarez E, Enjuanes L, Hilgenfeld R. 2015. A G-quadruplex-binding macrodomain within the "SARS-unique domain" is essential for the activity of the SARS-coronavirus replicationtranscription complex. Virology 484:313-22
143. Fathers C, Drayton RM, Solovieva S, Bryant HE. 2012. Inhibition of poly(ADP-ribose) glycohydrolase (PARG) specifically kills BRCA2-deficient tumor cells. Cell Cycle 11:990-97
144. Feng FY, de Bono JS, Rubin MA, Knudsen KE. 2015. Chromatin to clinic: The molecular rationale for PARP1 inhibitor function. Mol. Cell 58:925-34
145. MinW, Wang ZQ. 2009. Poly (ADP-ribose) glycohydrolase (PARG) and its therapeutic potential. Front. Biosci. 14:1619-26
146. Finch KE, Knezevic CE, Nottbohm AC, Partlow KC, Hergenrother PJ. 2012. Selective small molecule inhibition of poly(ADP-ribose) glycohydrolase (PARG). ACS Chem. Biol. 7:563-70
147. Islam R, Koizumi F, Kodera Y, Inoue K, OkawaraT, MasutaniM. 2014. Design and synthesis of phenolic hydrazide hydrazones as potent poly(ADP-ribose) glycohydrolase (PARG) inhibitors. Bioorg. Med. Chem. Lett. 24:3802-6
148. Tanaka Y, Matsunami N, Itaya A, Yoshihara K. 1981. Histone-dependent ADP-ribosylation of low molecular nucleotide by poly(ADP-ribose) polymerase. J. Biochem. 90:1131-39
149. Baltzinger M, Ebel JP, Remy P. 1986. Accumulation of dinucleoside polyphosphates in Saccharomyces cerevisiae under stress conditions. High levels are associated with cell death. Biochimie 68:1231-36
150. Marriott AS, CopelandNA, Cunningham R, WilkinsonMC, McLennan AG, JonesNJ. 2015. Diadenosine 5-, 5- -P1, P4-tetraphosphate (Ap4A) is synthesized in response to DNA damage and inhibits the initiation of DNA replication. DNA Repair 33:90-100